Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
Matthew J. Walter, Dong Shen, Jin Shao, et al.
Leukemia (2013) Vol. 27, Iss. 6, pp. 1275-1282
Open Access | Times Cited: 271

Showing 1-25 of 271 citing articles:

Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 26, pp. 2488-2498
Open Access | Times Cited: 4106
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie, Charles Lu, Jiayin Wang, et al.
Nature Medicine (2014) Vol. 20, Iss. 12, pp. 1472-1478
Open Access | Times Cited: 1724
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, et al.
Blood (2013) Vol. 122, Iss. 22, pp. 3616-3627
Open Access | Times Cited: 1711
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Torsten Haferlach, Yasunobu Nagata, Vera Grossmann, et al.
Leukemia (2013) Vol. 28, Iss. 2, pp. 241-247
Open Access | Times Cited: 1420
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola, et al.
Blood (2014) Vol. 125, Iss. 9, pp. 1367-1376
Open Access | Times Cited: 874
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Terrence N. Wong, Giridharan Ramsingh, Andrew L. Young, et al.
Nature (2014) Vol. 518, Iss. 7540, pp. 552-555
Open Access | Times Cited: 789
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling, Christopher J. Gibson, Benjamin L. Ebert
Nature reviews. Cancer (2016) Vol. 17, Iss. 1, pp. 5-19
Open Access | Times Cited: 603
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
Rafael Bejar, Allegra M. Lord, Kristen E. Stevenson, et al.
Blood (2014) Vol. 124, Iss. 17, pp. 2705-2712
Open Access | Times Cited: 522
Emerging patterns of somatic mutations in cancer
Ian R. Watson, Koichi Takahashi, P. Andrew Futreal, et al.
Nature Reviews Genetics (2013) Vol. 14, Iss. 10, pp. 703-718
Open Access | Times Cited: 484
SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
Christopher A. Miller, Brian S. White, Nathan D. Dees, et al.
PLoS Computational Biology (2014) Vol. 10, Iss. 8, pp. e1003665-e1003665
Open Access | Times Cited: 451
Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes
Yasunobu Nagata, Vera Grossmann, Yusuke Okuno, et al.
Blood (2013) Vol. 122, Iss. 21, pp. 521-521
Open Access | Times Cited: 431
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms
Chantana Polprasert, Isabell Schulze, Mikkael A. Sekeres, et al.
Cancer Cell (2015) Vol. 27, Iss. 5, pp. 658-670
Open Access | Times Cited: 392
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, et al.
Nature Genetics (2016) Vol. 49, Iss. 2, pp. 204-212
Open Access | Times Cited: 382
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
Andrew S. Brohl, David A. Solomon, Wendy Chang, et al.
PLoS Genetics (2014) Vol. 10, Iss. 7, pp. e1004475-e1004475
Open Access | Times Cited: 380
Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation
Rafael Bejar, Kristen E. Stevenson, Bennett Adam Caughey, et al.
Journal of Clinical Oncology (2014) Vol. 32, Iss. 25, pp. 2691-2698
Open Access | Times Cited: 380
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 14, pp. 1584-1594
Open Access | Times Cited: 349
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
Ayana Kon, Lee‐Yung Shih, Masashi Minamino, et al.
Nature Genetics (2013) Vol. 45, Iss. 10, pp. 1232-1237
Closed Access | Times Cited: 348
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola, Matteo Giovanni Della Porta, Luca Malcovati
Blood (2013) Vol. 122, Iss. 25, pp. 4021-4034
Open Access | Times Cited: 329
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy
Michael Y. Zhang, Jane E. Churpek, Sioḃán Keel, et al.
Nature Genetics (2015) Vol. 47, Iss. 2, pp. 180-185
Open Access | Times Cited: 328
Alternative splicing and cancer: a systematic review
Yuanjiao Zhang, Jinjun Qian, Chunyan Gu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 304
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Cara Lunn Shirai, James N. Ley, Brian S. White, et al.
Cancer Cell (2015) Vol. 27, Iss. 5, pp. 631-643
Open Access | Times Cited: 270
Splicing-factor alterations in cancers
Olga Anczuków, Adrian R. Krainer
RNA (2016) Vol. 22, Iss. 9, pp. 1285-1301
Open Access | Times Cited: 256
Somatic SETBP1 mutations in myeloid malignancies
Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, et al.
Nature Genetics (2013) Vol. 45, Iss. 8, pp. 942-946
Open Access | Times Cited: 248
Tet2 restrains inflammatory gene expression in macrophages
Alyssa Cull, Brooke Snetsinger, Rena Buckstein, et al.
Experimental Hematology (2017) Vol. 55, pp. 56-70.e13
Open Access | Times Cited: 242
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Mikkael A. Sekeres, Megan Othus, Alan F. List, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 24, pp. 2745-2753
Open Access | Times Cited: 225
Page 1 - Next Page

Scroll to top